Evidence map›Paper›PMID 30302389›Full record

ArticleeNeuro

Selective Effects of the Loss of NMDA or mGluR5 Receptors in the Reward System on Adaptive Decision-Making.

Przemysław Eligiusz Cieślak, Woo-Young Ahn, Rafał Bogacz, Jan Rodriguez Parkitna

Open access · goldAbstract read
In one paragraph

Article in eNeuro. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 4 countries.

Przemysław Eligiusz CieślakDepartment of Molecular Neuropharmacology, Institute of Pharmacology of the Polish Academy of Sciences, 31-343, Krakow, Poland.ORCID 0000-0002-0543-8445
Woo-Young AhnDepartment of Psychology, Seoul National University, Seoul 08826, Korea.
Rafał BogaczMRC Brain Networks Dynamics Unit, Nuffield Department of Clinical Neurosciences, Oxford University, John Radcliffe Hospital, Oxford OX3 9DU, United Kingdom.ORCID 0000-0002-8994-1661
Jan Rodriguez ParkitnaDepartment of Molecular Neuropharmacology, Institute of Pharmacology of the Polish Academy of Sciences, 31-343, Krakow, Poland.
Maj Institute of Pharmacology · PLJohn Radcliffe Hospital · GBSeoul National University · KR

Funding

Medical Research Council MC_UU_12024/5
6 · The paper itself

Abstract

Selecting the most advantageous actions in a changing environment is a central feature of adaptive behavior. The midbrain dopamine (DA) neurons along with the major targets of their projections, including dopaminoceptive neurons in the frontal cortex and basal ganglia, play a key role in this process. Here, we investigate the consequences of a selective genetic disruption of NMDA receptor and metabotropic glutamate receptor 5 (mGluR5) in the DA system on adaptive choice behavior in mice. We tested the effects of the mutation on performance in the probabilistic reinforcement learning and probability-discounting tasks. In case of the probabilistic choice, both the loss of NMDA receptors in dopaminergic neurons or the loss mGluR5 receptors in D

Indexed as

Reinforcement, PsychologyAnimalsBehavior, AnimalDecision MakingDopamineDopaminergic NeuronsMaleMiceMice, TransgenicNeuronsReceptor, Metabotropic Glutamate 5Receptors, Dopamine D1Receptors, N-Methyl-D-AspartateRewardSignal TransductionDopamineGrm5 protein, mouseReceptor, Metabotropic Glutamate 5Receptors, Dopamine D1Receptors, N-Methyl-D-Aspartatedecision-makingdopamineglutamate receptorsmouse behaviorreinforcement learning

Identifiers

PMID30302389
PMCPMC6175304
OpenAlexW2884757460

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.